Related Experiment Video

Updated: Jun 17, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Cooperative nanomaterial system to sensitize, target, and treat tumors

Ji-Ho Park1, Geoffrey von Maltzahn, Mary Jue Xu

  • 1Materials Science and Engineering Program, University of California, San Diego, La Jolla, CA 92093, USA.

Proceedings of the National Academy of Sciences of the United States of America
|January 19, 2010
PubMed

Insights

This study introduces a dual-nanoparticle system that enhances cancer therapy. Localized heating activates targeted nanoparticles, significantly reducing tumor growth in preclinical models.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Therapy

Background:

  • Systemic nanoparticle delivery faces challenges due to rapid clearance by the mononuclear phagocyte system.
  • Targeted nanoparticles show limited success in improving therapeutic efficacy against cancer.
  • Developing effective nanoparticle-based cancer therapies requires overcoming biological barriers.

Purpose of the Study:

  • To develop a cooperative nanosystem combining gold nanorods (NR) and targeted nanoparticles for enhanced cancer treatment.
  • To investigate the role of localized hyperthermia in recruiting targeted nanoparticles to tumors.
  • To evaluate the therapeutic efficacy of the NR/LyP-1LP system in reducing tumor volume.

Main Methods:

  • Utilized gold nanorods (NR) as photothermal activators for localized tumor heating via near-infrared laser irradiation.
  • Developed targeted nanoparticles (magnetic nanoworms or doxorubicin-loaded liposomes) functionalized with LyP-1 peptide.
  • Assessed the binding of LyP-1 to p32 protein upregulated on tumor-associated cells post-heating.
  • Evaluated tumor volume reduction in mice with xenografted MDA-MB-435 tumors using the combined NR/LyP-1LP system.

Main Results:

  • Local tumor heating by NR accelerated the recruitment of targeted nanoparticles (LyP-1LP).
  • The LyP-1 peptide targeted p32 protein on tumor-associated cells, which was upregulated by thermal treatment.
  • The combined NR/LyP-1LP therapeutic system demonstrated significant reductions in tumor volume.
  • The cooperative system outperformed individual nanoparticles and untargeted cooperative systems in reducing tumor size.

Conclusions:

  • Cooperative nanosystems offer a promising strategy to overcome limitations in systemic nanoparticle delivery for cancer therapy.
  • Localized hyperthermia can enhance the accumulation and efficacy of targeted nanoparticles within tumors.
  • The NR/LyP-1LP system represents a novel and effective approach for preclinical cancer treatment.

More Related Videos

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

Biofunctionalization of Magnetic Nanomaterials06:40

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...